SAM
DYN icon

Smartleaf Asset Management’s Dyne Therapeutics DYN Stock Holding History

Smartleaf Asset Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3K Hold
769
– – ﹤0.01% 2121
2026
Q1 		$13.1K Buy
769
+214
+39% +$3.69K ﹤0.01% 2186
2025
Q4 		$10.7K Buy
555
+472
+569% +$8.94K ﹤0.01% 2371
2025
Q3 		$1.03K Buy
83
+74
+822% +$844 ﹤0.01% 2742
2025
Q2 		$86 Buy
+9
New +$99 ﹤0.01% 2693
2025
Q1 		– Sell
-31
Closed -$733 – 2901
2024
Q4 		$733 Sell
31
-14
-31% -$414 ﹤0.01% 2723
2024
Q3 		$1.52K Buy
45
+13
+41% +$517 ﹤0.01% 2565
2024
Q2 		$1.13K Buy
+32
New +$930 ﹤0.01% 2385

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Smartleaf Asset Management's DYN Position: Q2 2026 in Review

Smartleaf Asset Management held its Dyne Therapeutics (DYN) position steady in Q2 2026 at 769 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2121.

Smartleaf Asset Management first reported a position in DYN in Q2 2024 and has held it in 8 quarters since. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Smartleaf Asset Management held 769 shares of Dyne Therapeutics worth $16.3K as of Q2 2026.
  • Smartleaf Asset Management left its Dyne Therapeutics share count unchanged in Q2 2026.
  • Dyne Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2121 holding.
  • Smartleaf Asset Management first reported a position in Dyne Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.